Publications by authors named "Mohammed Milhem"

83Publications

Non-Conventional Treatments for Conventional Chondrosarcoma.

Cancers (Basel) 2020 Jul 19;12(7). Epub 2020 Jul 19.

Division of Oncology, Department of Internal Medicine, University of Iowa, Iowa City, IA 52242, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12071962DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409290PMC
July 2020

A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue Sarcomas.

Cancers (Basel) 2020 Jul 11;12(7). Epub 2020 Jul 11.

Division of Hematology, Oncology, and Blood and Marrow Transplantation, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12071873DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408640PMC
July 2020

Functional Genomic Screening Independently Identifies CUL3 as a Mediator of Vemurafenib Resistance via Src-Rac1 Signaling Axis.

Front Oncol 2020 3;10:442. Epub 2020 Apr 3.

Department of Molecular Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2020.00442DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169429PMC
April 2020

A Retrospective Analysis of Clinical Trial Accrual of Patients Presented in a Multidisciplinary Tumor Board at a Tertiary Health Care Center and Associated Barriers.

Oncol Res Treat 2020 27;43(5):196-203. Epub 2020 Mar 27.

Division of Hematology, Oncology and Blood and Marrow Transplantation, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000506840DOI Listing
September 2020

Cancer Cells Resist Mechanical Destruction in Circulation via RhoA/Actomyosin-Dependent Mechano-Adaptation.

Cell Rep 2020 03;30(11):3864-3874.e6

Department of Molecular Physiology and Biophysics, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA; Cancer Biology Program, Biomedical Sciences, University of Iowa, Iowa City, IA 52242, USA; Holden Comprehensive Cancer Center, Iowa City, IA 52242, USA; Departments of Pathology, Urology and Radiation Oncology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2020.02.080DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219793PMC
March 2020

Melanoma Characteristics in Patients with a History of UV Tanning Bed Usage.

Ann Otol Rhinol Laryngol 2020 Jul 6;129(7):684-688. Epub 2020 Feb 6.

Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, IA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0003489420904744DOI Listing
July 2020

Efficacy and Adverse Events in Metastatic Melanoma Patients Treated with Combination BRAF Plus MEK Inhibitors Versus BRAF Inhibitors: A Systematic Review.

Cancers (Basel) 2019 Dec 5;11(12). Epub 2019 Dec 5.

Department of Internal Medicine, Division of Hematology and Oncology, University of Iowa, Iowa City, IA 52242, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11121950DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966686PMC
December 2019

Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma.

Cancer 2020 01 11;126(1):105-111. Epub 2019 Sep 11.

Pennsylvania Oncology Hematology Associates, University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.32515
Publisher Site
http://dx.doi.org/10.1002/cncr.32515DOI Listing
January 2020

Durable Clinical Benefit in Patients with Advanced Cutaneous Melanoma after Discontinuation of Anti-PD-1 Therapies Due to Immune-Related Adverse Events.

J Oncol 2019 25;2019:1856594. Epub 2019 Jul 25.

Division of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, 200 Hawkins Dr., Iowa City, IA 52242, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2019/1856594DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683789PMC
July 2019

Ipilimumab-induced hypophysitis, a single academic center experience.

Pituitary 2019 Oct;22(5):488-496

Division of Endocrinology, Department of Medicine, Oregon Health and Science University, Portland, OR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11102-019-00978-4DOI Listing
October 2019

The clinical characteristics of melanoma with BRAF V600R mutation: a case series study.

Melanoma Res 2020 02;30(1):107-112

Medicine, Division of Hematology and Oncology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000630DOI Listing
February 2020

Clinical Challenges with Talimogene Laherparepvec: Cured Lymph Nodes Masquerading as Active Melanoma.

Case Rep Oncol Med 2019 7;2019:4683531. Epub 2019 Mar 7.

Department of Hematology, Oncology and Blood and Marrow Transplantation, University of Iowa Hospitals and Clinics, 200 Hawkins Dr, Iowa City, IA 52242, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2019/4683531DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431461PMC
March 2019

Clinical outcomes and toxicities of pazopanib administered orally in crushed form: Case reports and review of the literature.

J Oncol Pharm Pract 2020 Jan 8;26(1):232-235. Epub 2019 Apr 8.

Division of Hematology, Oncology, and Blood and Marrow Transplantation, University of Iowa Holden Comprehensive Cancer Center, Iowa City, IA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155219841108DOI Listing
January 2020

Advanced stage melanoma therapies: Detailing the present and exploring the future.

Crit Rev Oncol Hematol 2019 Jan 15;133:99-111. Epub 2018 Nov 15.

Department of Internal Medicine, Division of Hematology, Oncology and Blood and Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA, United States. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10408428183018
Publisher Site
http://dx.doi.org/10.1016/j.critrevonc.2018.11.002DOI Listing
January 2019

Sorafenib for Advanced and Refractory Desmoid Tumors.

N Engl J Med 2018 12;379(25):2417-2428

From Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center (M.M.G., W.D.T., N.H., N.P.A., R.A.L., Y.M., R.Y.) and Columbia University Vagellos College of Physicians and Surgeons and New York Presbyterian Hospital (L.H.S., G.K.S.), New York, and Northwell Cancer Institute and Cold Spring Harbor Laboratory, Lake Success (R.G.M.) - all in New York; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN (M.R.M.); Washington University School of Medicine, St. Louis (B.A.V.T.); M.D. Anderson Cancer Center, University of Texas, Houston (V.R.); Mayo Clinic in Florida, Jacksonville (S.A.); Yale University, New Haven, CT (H.A.D.); University Health Network Princess Margaret Cancer Centre, Toronto (A.A.G.); University of Iowa-Holden Comprehensive Cancer Center, Iowa City (M.M.M.); University of Alabama at Birmingham Cancer Center, Birmingham (R.M.C.); Fox Chase Cancer Center, Philadelphia (S.M.); Georgetown University, Lombardi Comprehensive Cancer Center, Washington, DC (M.J.P.); Duke Cancer Institute, Duke University Medical Center, Durham (R.F.R.), and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill (E.B.) - both in North Carolina; Dayton National Cancer Institute Community Oncology Research Program, Dayton, OH (T.S.); National Cancer Institute, Bethesda, MD (J.J.W.); and the Alliance Statistics and Data Center, Mayo Clinic, Scottsdale, AZ (A.C.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1805052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447029PMC
December 2018

Cutaneous malignant melanoma of the oral cavity following skin graft reconstruction: Case report.

Head Neck 2019 02 7;41(2):E26-E29. Epub 2018 Dec 7.

Department of Radiation Oncology, University of Iowa Hospitals and Clinics, Iowa City, Iowa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.25417DOI Listing
February 2019

Discrepancy between treatment goals documentation by oncologists and their understanding among cancer patients under active treatment with chemotherapy.

Eur J Cancer Care (Engl) 2019 Mar 3;28(2):e12973. Epub 2018 Dec 3.

Division of Hematology, Oncology, and Blood and Marrow Transplantation, University of Iowa Carver College of Medicine, Iowa City, Iowa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ecc.12973DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416062PMC
March 2019

Toxicities with targeted therapies after immunotherapy in metastatic melanoma.

Melanoma Res 2018 12;28(6):600-604

Internal Medicine, Division of Hematology, Oncology and Blood and Marrow Transplantation, University of Iowa Carver College of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000493DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436382PMC
December 2018

Improved survival for extremity soft tissue sarcoma treated in high-volume facilities.

J Surg Oncol 2018 Jun 6;117(7):1479-1486. Epub 2018 Apr 6.

Department of Orthopaedics and Rehabilitation, University of Iowa, Iowa City, Iowa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.25052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322682PMC
June 2018

A Phase I/II Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and a Histone Deacetylase Inhibitor (Valproic Acid) in Advanced Sarcomas.

Cancers (Basel) 2018 Feb 17;10(2). Epub 2018 Feb 17.

Division of Hematology, Oncology, and Blood and Marrow Transplantation, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers10020053DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836085PMC
February 2018

Gastrointestinal stromal tumors-are we stuck and the way forward.

Transl Gastroenterol Hepatol 2017 20;2:93. Epub 2017 Nov 20.

Department of Hematology, Oncology and Blood and Marrow Transplantation, the Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tgh.2017.11.07DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723736PMC
November 2017

Insights into the Proteome of Gastrointestinal Stromal Tumors-Derived Exosomes Reveals New Potential Diagnostic Biomarkers.

Mol Cell Proteomics 2018 03 14;17(3):495-515. Epub 2017 Dec 14.

From the ‡Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, 3901 Rainbow Blvd., 4005 WHE, MS3040, Kansas City, Kansas 66160.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/mcp.RA117.000267DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836374PMC
March 2018

Obesity Does Not Exacerbate the Protumorigenic Systemic Environment in Sarcoma Subjects.

Immunohorizons 2017 Jun 5;1(4):20-28. Epub 2017 Jun 5.

Department of Urology, University of Iowa, Iowa City, IA 52242.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/immunohorizons.1700001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711445PMC
June 2017

Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb study.

Oncotarget 2017 Oct 26;8(51):89182-89193. Epub 2017 Sep 26.

Department of Hematology, Oncology and Blood and Marrow Transplantation and the Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.21269DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687680PMC
October 2017

Redox active metals and HO mediate the increased efficacy of pharmacological ascorbate in combination with gemcitabine or radiation in pre-clinical sarcoma models.

Redox Biol 2018 04 28;14:417-422. Epub 2017 Sep 28.

Free Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, The University of Iowa, Iowa City, IA 52242, United States. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22132317173058
Publisher Site
http://dx.doi.org/10.1016/j.redox.2017.09.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651553PMC
April 2018

Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma.

J Clin Oncol 2018 06 5;36(17):1658-1667. Epub 2017 Oct 5.

Jason Chesney, J. Graham Brown Cancer Center, University of Louisville, Louisville, KY; Igor Puzanov, Roswell Park Cancer Institute, Buffalo; Philip Friedlander, Mt Sinai School of Medicine, New York, NY; Frances Collichio, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Parminder Singh, Mayo Clinic, Phoenix, AZ; Mohammed M. Milhem, University of Iowa Hospitals and Clinics, Iowa City, IA; John Glaspy, University of California Los Angeles School of Medicine; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles; Lisa Chen, Jenny J. Kim, and Jennifer Gansert, Amgen, Thousand Oaks, CA; Merrick Ross, MD Anderson Cancer Center, Houston, TX; Claus Garbe, University Hospital Tuebingen, Tuebingen; Axel Hauschild, University of Kiel, Kiel, Germany; Theodore F. Logan, Indiana University Simon Cancer Center, Indianapolis, IN; Celeste Lebbé, Assistance Publique-Hôpital De Paris Dermatology and CIC Hôpital Saint Louis University Paris Diderot Sorbonne, Institut National de la Santé et de la Recherche Médicale U976, Paris, France; Robert H.I. Andtbacka, University of Utah, Salt Lake City, UT; and Howard L. Kaufman, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.73.7379
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.73.7379DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075852PMC
June 2018

Quality-of-life outcomes in patients with advanced melanoma: A review of the literature.

Pigment Cell Melanoma Res 2017 Jan 13;30(6):511-520. Epub 2017 Oct 13.

Department of Internal Medicine, Division of Hematology and Medical Oncology, University of Iowa Hospitals and Clinics and Holden Comprehensive Cancer Center, Iowa City, IA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12647DOI Listing
January 2017

Ipilimumab: from preclinical development to future clinical perspectives in melanoma.

Future Oncol 2017 Mar 24;13(7):625-636. Epub 2016 Nov 24.

Department of Hematology, Oncology & Blood & Marrow Transplantation & the Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2016-0385DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618953PMC
March 2017

Pembrolizumab Therapy Triggering an Exacerbation of Preexisting Autoimmune Disease: A Report of 2 Patient Cases.

J Investig Med High Impact Case Rep 2016 Oct-Dec;4(4):2324709616674316. Epub 2016 Oct 25.

Department of Internal Medicine, Divison of Hematology/Oncology, University of Iowa Hospitals & Clinics, Iowa City, IA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2324709616674316DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084516PMC
October 2016

Pityriasis lichenoides chronica-like drug eruption developing during pembrolizumab treatment for metastatic melanoma.

JAAD Case Rep 2016 Jul 17;2(4):343-5. Epub 2016 Aug 17.

Department of Dermatology, University of Iowa Hospitals and Clinics, Iowa City, Iowa; Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, Iowa.

View Article

Download full-text PDF

Source
https://pdfs.semanticscholar.org/0fbe/60ab69ee0d95599b0e17e0
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S235251261630062
Publisher Site
http://dx.doi.org/10.1016/j.jdcr.2016.06.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992012PMC
July 2016

Keratoacanthoma-appearing melanoma metastases in a patient receiving pembrolizumab therapy.

JAAD Case Rep 2016 May 27;2(3):247-9. Epub 2016 Jun 27.

Department of Dermatology, University of Iowa Hospitals and Clinics, Iowa City, Iowa; Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, Iowa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jdcr.2016.04.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927649PMC
May 2016

Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma.

J Clin Oncol 2016 08 13;34(22):2619-26. Epub 2016 Jun 13.

Igor Puzanov, Vanderbilt University, Nashville, TN; Mohammed M. Milhem, University of Iowa, Iowa City, IA; David Minor, California Pacific Melanoma Center, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles; and Ai Li, Lisa Chen, Michael Chastain, Kevin S. Gorski, Abraham Anderson, and Jeffrey Chou, Amgen, Thousand Oaks, CA; Howard L. Kaufman, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; and Robert H.I. Andtbacka, University of Utah, Salt Lake City, UT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.1529DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189507PMC
August 2016

Imatinib Dosing in Gastrointestinal Stromal Tumors (GISTs): When, How Much, and How Long?

Curr Clin Pharmacol 2015 ;10(4):311-20

Department of Hematology and Oncology, C 32 GH, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1574884710666151020100518DOI Listing
August 2016

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.

J Clin Oncol 2016 Mar 14;34(8):786-93. Epub 2015 Sep 14.

George D. Demetri, Dana-Farber Cancer Institute and Ludwig Center at Harvard, Boston, MA; Margaret von Mehren, Fox Chase Cancer Center; Arthur Staddon, University of Pennsylvania, Philadelphia; Hussein Tawbi, University of Pittsburgh Cancer Institute, Pittsburgh, PA; Robin L. Jones, Seattle Cancer Care Alliance, Seattle, WA; Martee L. Hensley, Memorial Sloan Kettering Cancer Center; Robert G. Maki, Mount Sinai Medical Center, New York, NY; Scott M. Schuetze, University of Michigan, Ann Arbor, MI; Mohammed Milhem, University of Iowa Hospitals and Clinics, Iowa City, IA; Anthony Elias, University of Colorado Cancer Center, Aurora, CO; Kristen Ganjoo, Stanford Hospital and Clinics, Stanford, CA; Brian A. Van Tine, Washington University in St Louis, St Louis, MO; Alexander Spira, Virginia Cancer Specialists, Fairfax, VA; Andrew Dean, St John of God Hospital-Bendat Cancer Centre, Subiaco, Western Australia, Australia; Nushmia Z. Khokhar, Youn Choi Park, Roland E. Knoblauch, and Trilok V. Parekh, Janssen Research & Development, Raritan, NJ; and Shreyaskumar R. Patel, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2015.62.4734
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.62.4734DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070559PMC
March 2016

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.

J Clin Oncol 2015 Sep 26;33(25):2780-8. Epub 2015 May 26.

Robert H.I. Andtbacka, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Howard L. Kaufman, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Frances Collichio, University of North Carolina Medical Center, Chapel Hill, NC; Thomas Amatruda, Minnesota Oncology, Fridley, MN; Neil Senzer, Mary Crowley Cancer Research Center, Dallas; Merrick Ross, University of Texas MD Anderson Cancer Center, Houston, TX; Jason Chesney, University of Louisville, Louisville, KY; Keith A. Delman, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA; Lynn E. Spitler, Northern California Melanoma Center, San Francisco; Gregory A. Daniels, University of California San Diego Medical Center, Moores Cancer Center, La Jolla; Yining Ye, Bin Yao, Ai Li, Ari Vander Walde, and Jennifer Gansert, Amgen, Thousand Oaks, CA; Igor Puzanov, Vanderbilt University, Nashville, TN; Sanjiv S. Agarwala, St Luke's University Hospital and Health Network, Bethlehem, and Temple University School of Medicine, Philadelphia, PA; Mohammed Milhem, University of Iowa Hospitals and Clinics, Iowa City, IA; Lee Cranmer, University of Arizona, Tucson, AZ; Brendan Curti, Earle A. Chiles Research Institute, Portland, OR; Karl Lewis, University of Colorado Cancer Center, Aurora, CO; Troy Guthrie, Baptist Cancer Institute, Jacksonville; Jonathan S. Zager, Moffitt Cancer Center, Tampa, FL; Gerald P. Linette, Washington University School of Medicine, St Louis, MO; Kevin Harrington, Institute of Cancer Research, Royal Marsden Hospital, London; Mark R. Middleton, National Institute for Health Research Biomedical Research Centre, Oxford, United Kingdom; Wilson H. Miller Jr, McGill University, Montreal, Quebec, Canada; and Susan Doleman and Robert S. Coffin, Amgen, Woburn, MA.

View Article

Download full-text PDF

Source
http://www.surgonc.org/docs/default-source/fellows-articles-
Web Search
http://jco.ascopubs.org/content/early/2015/06/16/JCO.2014.58
Web Search
http://jco.ascopubs.org/content/suppl/2015/05/26/JCO.2014.58
Web Search
http://dx.doi.org/10.1200/JCO.2014.58.3377DOI Listing
September 2015

Aberrant CpG methylation of the TFAP2A gene constitutes a mechanism for loss of TFAP2A expression in human metastatic melanoma.

Epigenetics 2014 Dec;9(12):1641-7

a Interdisciplinary Graduate Program in Molecular and Cellular Biology; Graduate College ; The University of Iowa ; Iowa City , IA USA ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/15592294.2014.988062DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622677PMC
December 2014

Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide).

Cancer Chemother Pharmacol 2014 Oct 26;74(4):691-7. Epub 2014 Jul 26.

Division of Hematology, Oncology and Bone and Marrow Transplantation, Department of Internal Medicine, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA, 52242, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-014-2501-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175037PMC
October 2014

Nelfinavir treatment of adenoid cystic carcinoma: A case report.

Pract Radiat Oncol 2012 Oct-Dec;2(4):e129-e132. Epub 2011 Oct 26.

Department of Radiation Oncology, University of Iowa, Iowa City, Iowa.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S187985001100300
Publisher Site
http://dx.doi.org/10.1016/j.prro.2011.09.003DOI Listing
March 2014

Sentinel node biopsy for head and neck desmoplastic melanoma: not a given.

Otolaryngol Head Neck Surg 2012 Aug 7;147(2):271-4. Epub 2012 Mar 7.

Department of Otolaryngology-Head and Neck Surgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0194599812439857DOI Listing
August 2012

Correlation of MTDH/AEG-1 and HOTAIR Expression with Metastasis and Response to Treatment in Sarcoma Patients.

J Cancer Sci Ther 2011 Dec;S5(4)

Department of Internal Medicine, University of Iowa, Iowa City, USA ; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612017PMC
December 2011

Leiomyosarcoma of the head and neck: a population-based analysis.

Arch Otolaryngol Head Neck Surg 2011 Sep;137(9):921-4

Department of Otolaryngology-Head and Neck Surgery, University of Iowa Hospitals and Clinics, Iowa City, 52242, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archoto.2011.147DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345042PMC
September 2011

Paclitaxel as neoadjuvant therapy for high grade angiosarcoma of the spleen: a brief report and literature review.

Clin Med Insights Oncol 2010 Oct 12;4:107-10. Epub 2010 Oct 12.

Department of Hematology and Oncology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.4137/CMO.S5329
Publisher Site
http://dx.doi.org/10.4137/CMO.S5329DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956477PMC
October 2010

Signaling pathways in adenoid cystic cancers: implications for treatment.

Cancer Biol Ther 2009 Oct 22;8(20):1947-51. Epub 2009 Oct 22.

Department of Radiation Oncology, University of Iowa Hospital and Clinics, Iowa City, IA, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638238PMC
http://dx.doi.org/10.4161/cbt.8.20.9596DOI Listing
October 2009

Cord blood stem cell expansion is permissive to epigenetic regulation and environmental cues.

Exp Hematol 2009 Sep 6;37(9):1084-95. Epub 2009 Jun 6.

Section of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago IL 60607, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2009.05.012DOI Listing
September 2009

A positive antinuclear antibody test predicts for a poor response to initial steroid therapy in adults with idiopathic thrombocytopenic purpura.

Ann Hematol 2008 Jun 12;87(6):459-62. Epub 2008 Feb 12.

Department of Hematology and Oncology, King Hussein Cancer Center, P.O. Box 1269, Al-Jubeiha, Amman, Jordan.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00277-008-0448-1
Publisher Site
http://dx.doi.org/10.1007/s00277-008-0448-1DOI Listing
June 2008

Jordan palliative care initiative: a WHO Demonstration Project.

J Pain Symptom Manage 2007 May;33(5):628-33

Cancer Control and Palliative Care, World Health Organization, World Health Organization Collaborating Center for Palliative Cancer Care, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2007.02.032DOI Listing
May 2007

Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents.

Exp Hematol 2006 Feb;34(2):140-9

Section of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, 60607, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2005.10.002DOI Listing
February 2006

Modification of hematopoietic stem cell fate by 5aza 2'deoxycytidine and trichostatin A.

Blood 2004 Jun 19;103(11):4102-10. Epub 2004 Feb 19.

Section of Hematology/Oncology, University of Illinois Cancer Center, University of Illinois College of Medicine, Chicago, IL 60607, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2003-07-2431DOI Listing
June 2004